Skip to main content
SpringerLink
Log in

Schilddrüsenkarzinom

  • Chapter
Therapiekonzepte Onkologie

  • 30 Accesses

Zusammenfassung

Schilddrüsenkarzinome sind morphologisch und prognostisch heterogen. Die auf den Vorschlägen der WHO beruhende Klassifikation der Deutschen Gesellschaft für Endokrinologie und die Stadieneinteilung der UICC [6] siehe unten. Innerhalb der einzelnen histologischen Typen gibt es einzelne Besonderheiten; so hat das gekapselte und das okkulte papilläre Karzinom eine bessere Prognose als das histologisch grob-invasive [7]. Onkozytäre Varianten (eine Besonderheit der zytoplasmatischen Differenzierung) haben eine schlechtere Prognose [8–10].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Robbins J, Merino MJ, Boice JD Jr, Ron E, Ain KB, Alexander HR, Norton JA, Reynolds J (1991) Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med 115: 133–147

    Article  PubMed  CAS  Google Scholar 

  2. Levi F, Franceschi S, Te VC, Negri E, La Vecchia C (1990) Descriptive epidemiology of thyroid cancer in the Swiss Canton of Vaud. J Cancer Res Clin Oncol 116: 639–647

    Article  PubMed  CAS  Google Scholar 

  3. Glattre E, Akslen LA, Thoresen SO, Haldoren T (1990) Geographic patterns and trends in the incidence of thyroid cancer in Norway 1970–1986. Cancer Detect Prey 14: 625–631

    CAS  Google Scholar 

  4. Ishida T, Izuo M, Ogawa T, Kurebayashi J, Satoh K (1988) Evaluation of mass screening for thyroid cancer. Jpn J Clin Oncol 18: 289–295

    PubMed  CAS  Google Scholar 

  5. Schneider AB (1990) Radiation-induced thyroid tumors. Endocrinol Metab Clin North Am 19: 495–508

    PubMed  CAS  Google Scholar 

  6. UICC International Union Against Cancer (1987) Schilddrüse (ICD-O 193) In: Hermanek P, Scheibe O, Spiess) B, Wagner G (eds) TNM Klassifikation maligner Tumoren. Springer, Heidelberg, p 37–38

    Google Scholar 

  7. Schröder S, Dralle H, Rehpenning W, Böcker W (1987) Prognosekriterien des papillären Schilddrüsenkarzinoms. Langenbecks Arch Chir 371: 263

    Article  PubMed  Google Scholar 

  8. Bretzel RG, Schatz H (1985) Prognose bei Schilddrüsenkarzinom. Lebensversicherungsmedizin 6: 172–179

    Google Scholar 

  9. Cooper DS, Schneyer CR (1990) Follicular and Hurthle cell carcinoma of the thyroid. Endocrinol Metab Clin North Am 19: 577–591

    PubMed  CAS  Google Scholar 

  10. Reiners C, Hüfner M (1987) Nachsorge des papillären, follikulären und onkozytären Schilddrüsenkarzinoms. In: Bömer W, Reiners C (eds) Schilddrüsenmalignome. Diagnostik, Therapie und Nachsorge. Schattauer, Stuttgart, p 159–183

    Google Scholar 

  11. Byar DP, Green SB, Dor P, Williams D, Conon J, Gilse HA van, Mayer M, Sylvester RJ, Glabbeke M van (1979) A prognostic index for thyroid carcinoma. A study of the EORTC thyroid cancer cooperative group. Europ J Cancer 15: 1033–1041

    Google Scholar 

  12. Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester JA, Fremgen A (1990) Survival discriminants for differentiated thyroid cancer. Am J Surg 160: 344–347

    Article  PubMed  CAS  Google Scholar 

  13. Brennan MD, Bergstralh EJ, Heerden JA van, McConahey WM (1991) Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 66: 11–22

    Article  PubMed  CAS  Google Scholar 

  14. DeGroot LJ, Kaplan EL, McCormick M, Straus FH (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71: 414–424

    Article  PubMed  CAS  Google Scholar 

  15. Samaan NA, Schultz PN, Hickey RC (1988) Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab 67: 801–805

    Article  PubMed  CAS  Google Scholar 

  16. Palestini N, Cappello N, Cottino F, Durando R, Vecchiato D, Rendine S, Abeatici S (1989) Multifactorial study of prognostic factors in differentiated thyroid carcinoma. Ital J Surg Sci 19: 137–144

    PubMed  CAS  Google Scholar 

  17. Thoresen SO, Akslen LA, Glattre E, Haldorsen T, Lund EV, Schoultz M (1989) Survival and prognostic factors in differentiated thyroid cancer — a multivariate analysis of 1,055 cases. Br J Cancer 59: 231–235

    Article  PubMed  CAS  Google Scholar 

  18. McConahey WM, Taylor WF, Gorman CA, Woolner LB (1981) Retrospective study of 820 patients treated for papillary carcinoma of the thyroid at the Mayo Clinic between 1946 and 1971. In: Andreoli M, Monaco F, Robbins J (eds) Advances in Thyroid Neoplasia. Field Educational Italia, Rom

    Google Scholar 

  19. Benker G, Reiners C, Krause U, Bamberg M, Reinwein D (1988) Schilddrüsenkarzinome — aktuelle diagnostische und therapeutische Strategien. Internist 29: 564–569

    PubMed  CAS  Google Scholar 

  20. Benker G, Olbricht T, Reinwein D, Reiners C, Sauerwein W, Krause U, Mlynek ML, Hirche H (1990) Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherapy. Cancer 65: 1517–1520

    Google Scholar 

  21. Sautter-Bihl ML, Heinze HG (1992) Externe Strahlentherapie des differenzierten Schilddrüsenkarzinoms [The external radiotherapy of differentiated thyroid carcinoma]. Dtsch Med Wochenschr 117: 665–668

    Article  PubMed  CAS  Google Scholar 

  22. Junor EJ, Paul J, Reed NS (1992) Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 18: 83–88

    PubMed  CAS  Google Scholar 

  23. Logue JP, Hale RJ, Stewart AL, Duthie MB, Banerjee SS (1992) Primary malignant lymphoma of the thyroid: a clinicopathological analysis. Int J Radiat Oncol Biol Phys 22: 929–933

    Article  PubMed  CAS  Google Scholar 

  24. Rosier H, Birrer A, Löscher D, Kindser J (1992) Langzeitverläufe beim differenzierten Schilddrüsenkarzinom. Schweiz med Wschr 122: 1843–1857

    Google Scholar 

  25. Benker G, Windeck R, Reinwein D, Seeber S (1987) Differenzierte Karzinome der Thyreozyten: Medikamentöse Therapie (Chemotherapie). In: Bömer W, Reiners C (eds) Schilddrösenmalignome. Diagnostik, Therapie und Nachsorge. Schattauer, Stuttgart, p 143–158

    Google Scholar 

  26. Ahuja S, Ernest H (1987) Chemotherapy of thyroid carcinoma. J Endocrinol Invest 10: 303–310

    PubMed  CAS  Google Scholar 

  27. Benker G, Dabag S, Reinwein D, Seeber S (1984) Chemotherapie der Schilddrüsenkarzinome. In: Becker HD, Heinze HG (eds) Maligne Schilddrüsentumoren. Springer, Berlin Heidelberg New York, p 187–196

    Google Scholar 

  28. Lo Gerfo P, Feind C, Weber C, Ting W (1983) Immunotherapy of thyroid cancer by induction of autoimmune thyroiditis. Surgery 94: 959–965

    PubMed  CAS  Google Scholar 

  29. Rosenberg SA, Longo DL, Lotze MT (1989) Principles and application of biologic therapy. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles & practice of oncology. Lippincott, Philadelphia, p 301–347

    Google Scholar 

  30. Gottlieb JA, Stratton Hill C (1975) Adriamycin (NSC 123 127) therapy in thyroid carcinoma. Cancer Chemother Rep 6: 283–296

    Google Scholar 

  31. Burgess MH, Stratton Hill C (1978) Chemotherapy in the management of thyroid cancer. In: Greenfield LD (ed) Thyroid cancer. CRC Press, Palm Beach, Florida, p 233

    Google Scholar 

  32. Shimaoka K, Schoenfeld DA, Dewys WD, Creech RH, DeConti R (1985) A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 56: 2155–2160

    Article  PubMed  CAS  Google Scholar 

  33. Schell übl H, Raue F, Ziegler R (1990) Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase li study. J Cancer Res Clin Oncol 116: 21–23

    Google Scholar 

  34. Kim JH, Leeper RD (1987) Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer 60: 2372–2375

    Article  PubMed  CAS  Google Scholar 

  35. Tennvall J, Tallroth E, Hassan A el, Lundell G, Akerman M, Biorklund A, Blomgren H, Lowhagen T, Wallin G (1990) Anaplastic thyroid carcinoma. Doxorubicin, hyperfractionated radiotherapy and surgery. Acta Oncol 29: 1025–1028

    Google Scholar 

  36. Rogers JD, Lindberg RD, Stratton Hill C, Gehan E (1974) Spindle and giant cell carcinoma of the thyroid: a different therapeutic approach. Cancer 34: 1328–1332

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Benker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Benker, G. (1993). Schilddrüsenkarzinom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10495-8_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56872-8

  • Online ISBN: 978-3-662-10495-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation